Current Research in Neurobiology

Aims & Scope

(CRNEUR), a new primary research journal from Elsevier.

CRNEUR publishes timely original papers, short communications, resources and news & views that cover any aspect of the field of neural science from molecules to mind.

We ambitiously aim to be the neuroscientific community's preferred venue for publishing and one that scientists, funders, charities, government bodies and the public can count on for timely discoveries and advances of the highest quality.

Current Research in Neurobiology is a gold open access (OA) journal, which means articles are permanently and freely available.

It is a companion to the highly regarded review journal Current Opinion in Neurobiology (CONEUR; 2019 Journal Impact Factor 6.267, CiteScore 10.8) and is part of the Current Opinion and Research (CO+RE) suite of journals.

All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.

Current Research in Neurobiology topics include: fundamental (discovery) to clinically- or translationally -relevant neural science across the gamut of relevant animal model systems or humans, covering timely topics on structure, function, evolution, sensation, perception, cognition and mind, either in individually-varying 'typical' neural systems or sub-clinical and clinical areas of interest aimed at advancing knowledge or diagnosis, prognosis and treatment options.

We also encourage meta-neuroscience, such as empirically robust papers assessing or advancing welfare, ethical issues or efforts to improve research culture and to make it more inclusive.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Chemical Engineering, Medicine and Neuroscience, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Chemical Engineering, Medicine and Neuroscience, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,500.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.